Pharma seems to favor drugs and treatments which manage rather than cure (outlier in the HEP C cure regimen). Treatments can be used for years and develop an ever-expanding cadre of patients with active prescriptions, while cures don’t continue to generate long-term revenues.
It’s like Pharma discovered King Gillette and realized the money was in the blades, not the razors.
So if Pharma ever discovers a drug which reverses tendon or ligament damage, you can rest assured the benefit stops when the drug is no longer administered. It will be like minoxidil all over again.
Great food for thought, Will, and I like the way you read the medical literature!
That CRSPR stuff is wild.
Pharma seems to favor drugs and treatments which manage rather than cure (outlier in the HEP C cure regimen). Treatments can be used for years and develop an ever-expanding cadre of patients with active prescriptions, while cures don’t continue to generate long-term revenues.
It’s like Pharma discovered King Gillette and realized the money was in the blades, not the razors.
So if Pharma ever discovers a drug which reverses tendon or ligament damage, you can rest assured the benefit stops when the drug is no longer administered. It will be like minoxidil all over again.